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INTRODUCTION
The incidence of breast cancer–related lymphedema 
(BCRL) has been reported to range from 4% to 62.5%.1 
Several studies have found that lymphovenous anastomo-
sis (LVA) is effective in early-stage lymphedema but less 
effective in advanced-stage lymphedema.2–4 This may be 
due to the loss of the ability of the lymphatic vessels to 
adequately transfer lymph fluid in advanced stages of 
lymphedema. Another reason could be because most of 
the patent lymphatic vessels suitable for lymphovenous 
anastomosis are deteriorated or difficult to find within 
the fibrotic tissues in severely lymphedematous limbs.2–4 
Vascularized lymph node (VLN) transfer is typically re-
served for patients with Cheng’s Lymphedema Grade II to 
IV lymphedema and with complete occlusion detected on 
lymphoscintigraphy.2–5 VLN transfer has been described in 
both animal and human studies.6,7
The mechanism by which VLN transfer alleviates the 
symptoms of lymphedema continues to be an emerging 
science; however, theories have been proposed.8–15 One 
theory is the induction of lymphangiogenesis and recon-
stitution of lymphatic channels with transfer of lymph 
nodes to the affected limb.8,11,14,15 Another theory is that 
VLNs behave like the motor of a pump that absorbs inter-
stitial fluids and subsequently diverts that fluid to the ve-
nous circulation.9,10,12,13 The “catchment effect”  continues 
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to drain the lymph that when the subcutaneous interstitial 
pressure in the lymphedematous limb decreases, there is 
more lymph from the surrounding tissue that are recruit-
ed into the transferred lymph nodes.16 The “gravity effect” 
provides the propelling motion of swinging the arms re-
sults in fluid shifting toward distally.16 As such, by placing 
the pump distally where fluid accumulation is most, the 
drainage efficiency of the flap is maximized. This mecha-
nism is supported by the presence of indocyanine green 
(ICG) dye uptake in the venous system that is detected 
after peripheral intradermal or intranodal injection of 
the dye.9,10 It had already been shown that the length of 
ICG latency period has an inverse relationship with the 
degree of circumference reduction when assessing the im-
pact of the latency period in relation to clinical improve-
ment.13 There was clinical evidence that transferring the 
VLN flap to a more distal recipient site such as the wrist 
results in reductions in arm circumference and more 
rapid movement of radiolabeled tracer on lymphoscintig-
raphy indicating improved lymphatic clearance.16,17 The 
other benefits of using a distal recipient site include an 
unscarred and nonoperated area with available recipient 
vessels and lymph fluid accumulation caused by gravity. 
Furthermore, the number of VLNs in the transferred flap 
is positively correlated with the degree of limb volume re-
duction.12 Therefore, choosing a VLN flap that has a high 
number of viable lymph nodes within it will heighten the 
chance of a successful outcome.
There are several donor sites available for VLN transfers; 
the most common include groin, submental, supraclavicu-
lar, lateral thoracic, omentum, and jejunal mesenteric.18–35 
Previous studies have demonstrated the effectiveness and 
benefits of groin and submental flaps.19,33,34,36 While each 
method has been studied individually, there have not been 
outcomes studies to date of these 2 commonly used donor 
sites in direct comparison with each other accompanied 
with sufficient long-term follow-up. This study aims to 
compare the outcomes of vascularized groin lymph node 
(VGLN) and vascularized submental lymph node (VSLN) 
transfers with regard to their limb circumference improve-
ment and complications.
PATIENTS AND METHODS
A prospectively maintained database of patients at 
Chang Gung Memorial Hospital between January 2008 
and December 2016 who received VLN transfer for BCRL 
was reviewed after institutional review board approval. 
Before surgery, informed consent was obtained from pa-
tients. Risks, benefits, and treatment alternatives were dis-
cussed. Inclusion criteria included all patients with BCRL 
and had either VGLN or VSLN flap transfers. Exclusion 
criteria were any combined VLN transfer and LVA proce-
dures, VLN transfer combined with liposuction or partial 
excision, VLN transfer and using elbow or axilla as the 
recipient site. All patients had preoperative clinical evalu-
ation including lymphoscintigraphy, ICG lymphography, 
and radiographic work-up including computed tomogra-
phy evaluation of the affected limb, duplex ultrasonogra-
phy and magnetic resonance angiography of the donor 
sites to evaluate pedicle location, surrounding anatomical 
structures, and number of lymph nodes at the site.37,38 Pa-
tient circumferential measurements were obtained at the 
same follow-up evaluation in both submental and groin 
groups. Patient characteristics and demographics were 
collected and compared (Table 1). Harvest of the VGLN 
(Fig. 1) and VSLN (Fig. 2) flaps was performed as previ-
ously described.5,16,20,34 Recipient sites were at the wrist us-
ing a dorsal branch of radial artery or the ulnar artery as 
recipient. For the recipient vein, either cephalic or basilic 
vein was used. Both arterial and venous anastomoses were 
performed end-to-end. Superficial veins were used as re-
cipient veins of VLN transfers since the deep veins (co-
mitant veins of the major artery) are usually compressed 
by the lymphedematous tissue that results in a positive 
compartment pressure.
Outcomes of interest were collected prospectively 
including flap characteristics (recipient vein and artery, 
vessel diameter, number of lymph nodes within the flap), 
operative time, intraoperative and postoperative compli-
cations, and limb circumference changes (centimeters) at 
the follow-up. Perioperative complications recorded were 
re-exploration, hematoma, seroma, infection, and skin 
paddle loss. Postoperative complications recorded were 
cellulitis episodes. Time to wound healing and the need 
for split-thickness skin graft were recorded. Measurement 
of limb circumference was performed at each clinic visit 
using the previously described parameters of 10 cm above 
and below the elbow.1 Follow-up of patients occurred ini-
tially every month until 3 months, then every 3 months.
Using SPSS 17.0 statistical software (SPSS, Inc., Chicago, 
Ill.), statistical analysis was performed. A chi-square test was 
used to analyze all complication rates. A value of P ≤ 0.05 
was considered statistically significant. The nonparametric 
Mann-Whitney test was used for continuous variables.
RESULTS
A total of 43 patients underwent submental or groin 
VLN flap transfers to the wrist for upper extremity lymph-
edema and met inclusion and exclusion criteria during the 
study period. Thirteen (30.2%) underwent VGLN transfer 
and 30 (69.8%) had VSLN transfer; all VLN flaps survived. 
The mean age of all patients was 57.5 years (ranged, 38–78), 
with 56.1 years in the VGLN group and 58.8 years in the 
VSLN group, respectively (P = 0.8; Table 1). Average BMI 
was 27.5 for the entire study population with 26.1 in VGLN 
group and 28.8 in VSLN group (P = 07). The mean dura-
tion of lymphedema symptoms including swelling, heavi-
ness, and recurrent infections was 46.1 months (ranged, 
6–82 months). The VSLN group (52.1 months) had a sta-
tistically longer symptom duration than the VGLN group 
(40 months; P = 0.04).
In evaluating flap characteristics, similar donor vein 
diameter and artery diameter were found between VGLN 
and VSLN cohorts (Table 2). Average donor vein diam-
eter was 2.9 mm for the entire study group with 2.6 mm 
in the VGLN group and 3.2 mm in the VSLN group 
(P = 0.3). Mean donor artery diameter was 2.5 mm for the 
entire study group, with 2.1 mm in the VGLN group, and 
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3.2 mm in the VSLN group (P = 0.3). The average num-
ber of sizable lymph nodes for the entire study group was 
3.6, 3 in the VGLN group, and 4.2 in the VSLN group 
(P = 0.4). Harvest time of 108 minutes in the VSLN flap 
was statistically less than the 144 minutes in the VGLN flap 
(P = 0.04).
At a mean follow-up of 39.8 months, the mean limb 
circumferential reduction rate 48.4% in the VGLN group 
(Fig. 3) was statistically less than 55.5% for the VSLN 
group (Fig. 4) (P = 0.04).
It was found that VSLN patients had significantly fewer 
intraoperative salvage procedures (P = 0.04). The VGLN 
group also had significant fewer postoperative salvage pro-
cedures (P = 0.04). Complications in recipient site were 
38.5% in the VGLN cohort as compared with the 23.3% 
in the VSLN cohort but the difference was not statistically 
significant (P = 0.06). Donor-site lymphedema was statis-
tically significantly higher in the VGLN flap group than 
VSLN (7.7% versus 0%; P = 0.04). Total complication was 
statistically greater in the VGLN cohort than the VSLN 
(46.2% versus 23.3%; P = 0.02).
DISCUSSION
The reasons for the better functional recover in the 
VSLN group may be 2-fold: (1) greater number of lymph 
nodes, and (2) bigger size of donor vein in the VSLN 
group. Follow-up time was shorter in the VSLN group be-
cause it was used more frequently later in the study pe-
riod. However, the follow-up 28.6 ± 6.7 months is ample 
time to see a meaningful circumferential reduction rate 
postoperatively within the patient group.
In severe cases of limb lymphedema, VLN transfers are 
commonly utilized and have been shown to be beneficial 
in symptom improvement.2–5,39,40 A common advantage be-
tween these VLN donor sites is that they all allow primary 
donor-site closure. The ideal VLN flap has the following 
characteristics: maximum lymphatic drainage capacity 
with a greater number of sizable lymph nodes, absence of 
donor-site lymphedema, large diameter of donor vessels, a 
long pedicle, and inconspicuous scar.
Each of these various donor sites has pros and cons 
(Table 3). Axillary VLN transfer has been described and 
proposed as an alternative lymph node basin.24,25 The most 
notable concern for its use is the creation of iatrogenic up-
per limb lymphedema.35 The reverse mapping technique 
can be employed to avoid harvesting the lymph nodes that 
drain the upper limb.23 Lymph nodes in this location have 
greater anatomic variations in relation to the thoracodor-
sal and lateral thoracic vessels, especially for lymph node 
venous drainage. Common variations in vascular anatomy 
can lead to requiring 2 pedicle anastomoses or the thora-
codorsal nerve may be sacrificed.
Vascularized supraclavicular lymph node (VScLN) 
transfer has several advantages (Table 3). Proponents of 
this flap argue that the scar is well-concealed; however, 
should a patient wear common clothing such as a tank 
top, strapless dress, or wide-open necklines, the scar is 
certainly visible. This can be a concern, given that the 
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Fig. 2. a 52-year-old woman suffered from breast cancer-related lymphedema on right upper limb for 4 
years. a vascularized submental lymph node flap 8.5 × 2.2 cm was designed on right neck (a). three siz-
able lymph nodes (yellow arrows) were noted on the divided flap (B). two marginal mandibular nerves 
were well preserved under microscope (c). the donor site scar was inconspicuous 30 months postop-
eratively (D).
Fig. 1.  a 65-year-old woman who was a victim of right breast cancer postmastectomy, axillary lymph 
node dissection, and chemoradiation. She suffered from right upper limb lymphedema with 3 episodes 
of cellulitis per year for 2 years. She underwent right vascularized groin lymph node flap transfer to 
right dorsal wrist. Skin paddle 12 × 6 cm was designed on right groin below the inguinal ligament and 
close to common femoral vessels. One perforator was marked with pencil of medial Doppler (a). the 
superficial circumflex vessels were identified with vessel loop. the flap was elevated with short pedicle 
artery and 2 veins (c). the donor site of right groin 6 years after (D).
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is predominantly women.1,5,43,44 It was previously believed 
to bear no risk for secondary lymphedema; however, case 
reports have described incidences of upper limb lymph-
edema developing after harvest of VScLN.18,27,28 Disadvan-
tages with the VScLN flap include damage to the accessory 
nerve and brachial plexus, chyle leak, and lower number 
of lymph nodes in anatomic studies.32,38 Furthermore, a 
common sequela of this flap elevation is the sacrifice of 
supraclavicular nerves, which is unavoidable in the course 
of this flap’s elevation, and causes numbness of the supe-
rior chest region.
Vascularized omentum lymph node (VOLN) flap 
transfer is beneficial such that the scars are almost unde-
tectable assuming it is performed laparoscopically. It is 
also rich in number of lymph nodes. But possibly the most 
enticing for its use is that there is no risk of iatrogenic 
lymphedema.21,26,29 Furthermore, its immunologic potency 
is a characteristic only in the VOLN but not in other VLN 
flaps.29 There are disadvantages to the VOLN flap, which 
include bowel perforations, pancreatitis, internal bleed-
ing, and damage to the intra-abdominal organs. Even 
when performed laparoscopically and by a very skilled sur-
geon, the abdominal cavity is violated and harvesting the 
VOLN flap results in adhesions that can make a patient 
more prone to small bowel obstructions in the future. As 
with all laparoscopic procedures, there is the possibility 
of conversion to an open procedure that would increase 
the size of the scars significantly along with an increase in 
associated donor-site morbidity. Due to the extremely pli-
able, flaccid, short, and thin nature of the gastroepiploic 
vessels, it is more prone to kinking of its extensive vascula-
ture. It is necessary to take care in meticulously unraveling 
the omentum after it is retrieved from the laparoscopic 
specimen retrieval bag to ensure proper orientation to 
avoid ischemia and necrosis. There is also a theoretical 
risk of acute pancreatitis due to the close proximity of dis-
section to this organ.45 Finally, the VOLN has an absence 
of a skin paddle to provide coverage of the recipient site. 
Thus, the pedicle is in danger of being compressed es-
pecially with a tight primary closure of the recipient site. 
Additional skin graft can usually be used in VOLN flaps 
to close the recipient site with less tension. Should a skin 
graft be used instead, an unsightly appearance results as is 
expected with using split-thickness skin grafts, which may 
cause scarring and thereafter compromise the function of 
the lymph nodes. The skin paddle normally aids with flap 
monitoring, which is not an option in using VOLN flaps.
The groin flap is a procedure that most plastic sur-
geons are familiarized with.5,16,19,20 One of the main ad-
vantages of the VGLN flap is that it grants a substantial 
number of lymph nodes. The scar is also well-concealed 
with common everyday clothing. However, the VGLN 
transfer does have its drawbacks. The most concerning 
hazard is iatrogenic secondary lower limb lymphede-
ma46,47 7.7% in this VGLN group in this study, but only 1 
of 36 VGLN flap transfer (2.8%) patients developed do-
nor-site lymphedema in the senior author’s experience 
without reverse lymphatic mapping. Many surgeons have 
also found that it has a high rate of donor-site seroma 
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inferior epigastric perforator flap, but this was not found 
in this study. Studies regarding anatomical landmarks 
and reverse lymphatic mapping can make the use of the 
VGLN flap safer but cannot fully eliminate this risk.23,37,48 
The VGLN flap is much bulkier than the VSLN flap, 
which makes the appearance of recipient site initially un-
sightly. Subsequent revisional and debulking procedures 
are usually requested by  patients.
Fig. 3. the preoperative front view of case 1 (a) and postoperative 48 months follow-up front view (B). 
the circumferential difference was improved from 52% to 18%.
Fig. 4. the preoperative front view of case 2 (a) and postoperative 30 months follow-up front view (B). 
the circumferential difference was improved from 32% to 10%.
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The VSLN flap has some disadvantages in the hands 
of the inexperienced surgeon.5,34,36,42 There is a risk of in-
jury to the marginal mandibular branch of the facial nerve 
innervated facial muscles including depressor labii infe-
rioris muscle, depressor anguli oris muscle, and mentalis 
muscle, which can be avoided with delicate dissection un-
der microscope. Many critics state that the donor-site scar 
under the mandible is visible. However, the scar is not vis-
ible from the anterior or lateral front-on view of the face. 
It is only when the head tilted back can the scar be seen in 
the worm’s eye view. This is a pose that few people adopt 
on a day-to-day basis. Furthermore, in the more elderly 
patient or middle-aged patient with excess facial and neck 
skin laxity, VSLN has the added benefit of rejuvenating 
and tightening the appearance of the neck. With modi-
fications to the earlier techniques, there is the option to 
not take the level Ia lymph nodes, thus allowing the ante-
rior belly of the digastric muscle to not be disturbed while 
taking only level Ib lymph nodes within the flap. Recent 
modifications to this technique partially preserve the me-
dial part of the platysma that may decrease the compro-
mise of lower lip depression function.49 Finally, and most 
importantly, the VSLN flap is most advantageous in that 
it has substantial number of lymph nodes per side with 
Table 3. Comparisons of Donor Sites of Vascularized Lymph Node Flap Transfer
Flap Advantages Disadvantages
Submental - No risk of donor-site lymphedema - Potential risk of damage to marginal mandibular nerve
 - Well-hidden scar, only visible from worm’s eye view - Partial resection of platysma muscle
 - Small skin paddle  
 - Large number of lymph nodes within flap  
 -  Potential effects of neck lift especially if bilateral and 
in older patients
 
 -  Option to only take Ib and not Ia level lymph nodes 
to preserve more platysma
 
Groin -  Well-hidden scar - Lower limb donor-site lymphedema
 - Can include large skin paddle - High rate of donor-site seroma
 - Lymphatic drainage anatomy known -  Bulky flap resulting in difficult inset and affecting appearance at 
distal recipient site
 - Large number of lymph nodes within flap
 - Can be harvested with DIEP flap  
Omental -  Well-hidden scar especially when laparoscopically 
harvested
- Risk of bowel perforation and intra-abdominal organ damage
 - Large number of lymph nodes within flap -  Potential of need to covert laparoscopic to open abdominal 
procedure
 - No risk of iatrogenic lymphedema to donor site -  Flaccid, pliable, and very prone to pedicle twisting and kinking 
resulting in compromised viability
  - No associated skin paddle for monitoring and decreasing ten-
sion for recipient site closure
  - Possible risk of acute pancreatitis, internal bleeding
  -Difficult to perform preoperative imaging for available number 
and location of lymph nodes
Supraclavicular -  Scar can be hidden if wearing top that is not 
 sleeveless or low neckline
-Sacrifice of supraclavicular nerve
 -  Potentially lower donor-site lymphedema than  
axillary and groin
- 
- Variable vascular venous supply
- Unreliable skin paddle
- Difficult dissection
- Upper limb donor-site lymphedema
- Potential damage to accessory nerve and brachial plexus
- Chyle leak








Axillary - Well-hidden scar - Upper limb donor-site lymphedema
 - Lymphatic drainage anatomy known - Potential need to sacrifice thoracodorsal nerve
 - - Absent lymph nodes if previous axillary dissection
 -  May be combined with latissimus dorsi myocutaneous 
flap
-  Anatomic lymph node variability from thoracodorsal to lateral 
thoracic vessels
  - Two sets of pedicle anastomosis may be needed
Jejunal  
mesenteric
-  Well-hidden scar especially when laparoscopically 
harvested
- Risk of bowel perforation and intra-abdominal organ damage
 -  No nerve damage -  Potential of need to covert laparoscopic to open abdominal 
procedure
 - No risk of iatrogenic lymphedema to donor site -  No associated skin paddle for monitoring and decreased tension 
for recipient-site closure
 -  Can be harvested in 2 sets and transferred to  
2 recipient sites
-  Difficult to perform preoperative imaging for available number 
and location of lymph nodes
 - Easy flap harvest -  Short and thin-walled pedicle
 - Pedicle size incompatible
  - Need skin graft to cover and close wound at distal recipient site
  - Difficult to monitor flap if the flap is buried
DIEP, deep inferior epigastric perforator.
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greater diameter of donor facial vein while bearing no risk 
for postoperative iatrogenic lymphedema.
There are several limitations to this study. This was a 
retrospective study on prospectively collected data, which 
can have its inherent bias and confounding factors. Sec-
ond, the sample of patients studied is relatively small; how-
ever, we chose to only focus on upper limb lymphedema 
to provide as homogeneous a study group as possible for 
comparison of the 2 VLN transfer groups. Although the 
study sample is small in absolute numbers, this study as-
sessed the largest group reported so far for comparing 
VSLN and VGLN flaps for BCRL. Certainly, the field of 
lymphedema surgery continues to be an emerging sci-
ence. Finally, this study compares clinical outcomes in 2 
of the most commonly used donor sites for VLN transfer; 
however, it does not compare the VGLN and VSLN flaps 
to other known VLN flap donor sites. Although studies 
have compared LVA with VLN transfer,40,41 this is the first 
study to compare 2 VLN transfer flaps in a direct head-to-
head comparison but certainly paves the way for future 
studies in comparing other donor sites.
There are several significant findings to this study. First, 
both VSLN and VGLN flaps are effective for BCRL, but the 
VSLN had significantly greater improvement in circumfer-
ential reduction rate. Second, cosmesis of VSLN is better 
than that of VGLN. The quality of the skin paddle has a bet-
ter appearance on the wrist when it is from the submental 
region than from the groin. The donor site scar under the 
chin is well hidden, provides a thin and nice scar, and in 
some patients, provides an added benefit of giving an aes-
thetic tightening effect of the chin and neck area similar to 
a small neck lift especially in bilateral cases. Third, the op-
erative time is shorter with the VSLN in comparison to the 
VGLN. This may in part be because the dissection required 
with the VSLN flap is less. Finally, total complication rate of 
the VSLN is less than that of the VGLN flap.
CONCLUSIONS
Vascularized groin and submental lymph node flaps 
are both effective surgical options in treating BCRL. 
The VSLN flap for BCRL provides more significant im-
provements in limb circumference, lesser total compli-
cation rate, a faster flap harvest time, and perhaps the 
most important factor: no risk of donor-site iatrogenic 
lymphedema.
Ming-Huei Cheng, MD, MBA, FACS
Division of Reconstructive Microsurgery
Department of Plastic and Reconstructive Surgery
Chang Gung Memorial Hospital
College of Medicine, Chang Gung University
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